Home/Adcendo/Lone H. Ottesen, MD, PhD
LH

Lone H. Ottesen, MD, PhD

Chief Medical Officer

Adcendo

Therapeutic Areas

Adcendo Pipeline

DrugIndicationPhase
ADCE-D01Soft Tissue SarcomaPhase 1/2